Literature DB >> 1349175

Germ-line and somatic p53 gene mutations in multifocal osteogenic sarcoma.

A Iavarone1, K K Matthay, T M Steinkirchner, M A Israel.   

Abstract

Multifocal osteogenic sarcoma patients without familial histories of increased tumor predisposition were examined for mutations in the highly conserved regions of the p53 gene. p53 point mutations were found in tumor DNA from each of the four patients we examined. A germ-line p53 mutation was detected in one of these patients, and a further rearrangement of the residual wild-type allele was detected in tumor tissue. p53 germ-line mutations can contribute to the enhanced predisposition to tumor development manifest in patients with multifocal osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1349175      PMCID: PMC525662          DOI: 10.1073/pnas.89.9.4207

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Polymorphism at codon 213 within the p53 gene.

Authors:  D Carbone; I Chiba; T Mitsudomi
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

Review 2.  Structural aspects of the p53 protein in relation to gene evolution.

Authors:  T Soussi; C Caron de Fromentel; P May
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

Review 3.  Multifocal osteosarcoma: a case report with review of the literature.

Authors:  J P Mahoney; S S Spanier; J L Morris
Journal:  Cancer       Date:  1979-11       Impact factor: 6.860

4.  Prospective study of a family cancer syndrome.

Authors:  F P Li; J F Fraumeni
Journal:  JAMA       Date:  1982-05-21       Impact factor: 56.272

5.  Characterization of deletions at the retinoblastoma locus in patients with bilateral retinoblastoma.

Authors:  K Kloss; P Währisch; V Greger; E Messmer; H Fritze; W Höpping; E Passarge; B Horsthemke
Journal:  Am J Med Genet       Date:  1991-05-01

6.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis.

Authors:  S J Baker; A C Preisinger; J M Jessup; C Paraskeva; S Markowitz; J K Willson; S Hamilton; B Vogelstein
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

7.  Analysis of DNA in fresh and fixed tissue by the polymerase chain reaction.

Authors:  B B Rogers; L C Alpert; E A Hine; G J Buffone
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

8.  Mechanisms of p53 loss in human sarcomas.

Authors:  L M Mulligan; G J Matlashewski; H J Scrable; W K Cavenee
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

Review 9.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

10.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

View more
  19 in total

Review 1.  Cancer risks from germline p53 mutations.

Authors:  T Frebourg; S H Friend
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

2.  Absence of hereditary p53 mutations in 10 familial leukemia pedigrees.

Authors:  C A Felix; D D'Amico; T Mitsudomi; M M Nau; F P Li; J F Fraumeni; D E Cole; J McCalla; G H Reaman; J Whang-Peng
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Metastatic or metachronous osteosarcoma: a clinical dilemma.

Authors:  S G Hasan Naqvi; Shah Alam Khan; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2009-03       Impact factor: 1.967

4.  Alterations of the p53, Rb and MDM2 genes in osteosarcoma.

Authors:  C W Miller; A Aslo; A Won; M Tan; B Lampkin; H P Koeffler
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

5.  Using a family history questionnaire to identify adult patients with increased genetic risk for sarcoma.

Authors:  A Schiavi; J Lavigne; R Turcotte; L Kasprzak; N Dumas; G Chong; C Freeman; M Alameldin; P Galiatsatos; L Palma; W D Foulkes
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

Review 6.  Inherited predisposition to glioma.

Authors:  Athanassios P Kyritsis; Melissa L Bondy; Jasti S Rao; Chrissa Sioka
Journal:  Neuro Oncol       Date:  2009-11-23       Impact factor: 12.300

7.  Seeding of osteosarcoma in the biopsy tract of a patient with multifocal osteosarcoma.

Authors:  Kriengkrai Iemsawatdikul; Charles A Gooding; Elisabeth L Twomey; Grace Eun Hye Kim; Robert E Goldsby; Inbal Cohen; Richard J O'Donnell
Journal:  Pediatr Radiol       Date:  2005-03-09

8.  Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma.

Authors:  L Diller; E Sexsmith; A Gottlieb; F P Li; D Malkin
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.

Authors:  S Venkatachalam; Y P Shi; S N Jones; H Vogel; A Bradley; D Pinkel; L A Donehower
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

Review 10.  Genome-Wide Association Studies in Glioma.

Authors:  Ben Kinnersley; Richard S Houlston; Melissa L Bondy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-01-30       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.